Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol-Myers Squibb discovers PD-1/PD-L1 interaction inhibitors

Oct. 18, 2018

New 5-HT2C receptor agonists described by AbbVie

Oct. 18, 2018

Novartis discloses protein atonal homolog 1 activators

Oct. 18, 2018

Pseudolysin inhibitors presented by Antabio SAS

Oct. 18, 2018

Beijing Jacobio Pharmaceuticals, Jacobio-Alpha Pharmaceuticals patent PTP2C inhibitors

Oct. 18, 2018

Merck & Co. discovers antimycobacterial oxazolidinones

Oct. 18, 2018

Aslan begins phase I study of ASLAN-004 for atopic dermatitis

Oct. 18, 2018

Hutchison China MediTech initiates phase I study in China with HMPL-523 for AML

Oct. 18, 2018

Transgene initiates phase I/II trial of TG-6002 in advanced gastrointestinal tumors

Oct. 18, 2018

GeNeuro gives update on pHERV-K antibody program for ALS

Oct. 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...